MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-18-0051088
Noble Medichem Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹318.18 Cr
▲ 23% YoY
Net profit · FY 2025
₹52.04 Lakh
Net margin 0.2%
EBITDA · FY 2025
₹13.17 Cr
EBITDA margin 4.1%
Authorised capital
₹5.14 Cr
Registered with MCA
Paid-up capital
₹2.49 Cr
Issued & subscribed
Open charges
₹42.12 Cr
Satisfied ₹32.9 Cr
Company age
34 yrs
Est. 1992
Employees · EPFO
226
Provident fund records
About Noble Medichem Private Limited
Data last updated:
Noble Medichem Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 October 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH1992PTC069250. Its GSTIN is 27AACCM5010D1Z2 (Maharashtra).
The company has an authorised share capital of ₹5.14 Cr and a paid-up capital of ₹2.49 Cr. It was formerly known as Manali Hill Resorts Private Limited. It is led by directors Mihir Bakul Kapadia and Anuj Dharmanath Pandey.
Its last annual general meeting (AGM) was held on 19 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹318.18 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹52.04 Lakh (net margin 0.2%) and EBITDA of ₹13.17 Cr (EBITDA margin 4.1%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years.
The company has about 226 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹42.12 Cr and satisfied charges of ₹32.9 Cr on record. Court records list 13 cases involving the company, including 6 filed by the company and 7 filed against it; 5 cases are pending. The company has 8 deals on record (6 secondary share transfers, 2 funding rounds), with disclosed funding of ₹34.99 Cr; the latest was in June 2024.
Noble Medichem Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0051088). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nobleplus.in.
Company details
CIN U24100MH1992PTC069250
Registration Number 069250
Incorporation Date 28 October 1992
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 19 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-18-0051088
CIN history
Noble Medichem has one previous CIN (Corporate Identification Number): U55101MH1992PTC069250. The current CIN is U24100MH1992PTC069250, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100MH1992PTC069250 | Current |
| U55101MH1992PTC069250 | Previous |
Recognitions & Rankings of Noble Medichem
Contact details
Noble Medichem Private Limited's registered office is in Mumbai, Maharashtra. Its website is nobleplus.in. Its e-mail address is in the company report.
- Email
- Website
- Registered Address3 Ground Floor Hemu Castle Chs Ltd, Dadabhai Road Vile Parle West, Mumbai, Maharashtra, India – 400056
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Noble Medichem Private Limited, buy the company report.
Comprehensive company report
Noble Medichem Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Noble Medichem is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Noble Medichem Private Limited, buy the company report.
Financials of Noble Medichem Private Limited
FY 2025 filings availableNoble Medichem Private Limited reported revenue of ₹318.18 Cr (up 23% YoY) for FY 2025.
Revenue · FY 2025
₹318.18 Cr ▲ 23%
Net profit · FY 2025
₹52.04 Lakh margin 0.2%
EBITDA · FY 2025
₹13.17 Cr margin 4.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 23%
3 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 70%
3 years · compounded
▲ 16%
Revenue has grown at a compounded annual rate (CAGR) of 18% over three years, including 23% growth in the latest year. EBITDA rose 70% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹318.18 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13.17 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹52.04 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.1% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Noble Medichem Private Limited, buy the company report.
Board of directors of Noble Medichem Private Limited
Noble Medichem has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mihir Bakul Kapadia | Director | 29 Aug 2007 | 19 Years 2 Months | Current |
| Anuj Dharmanath Pandey Also directs: Noble Medicals Private Limited, Noble Plus Online Private Limited | Director | 04 Dec 2018 | 7 Years 11 Months | Current |
Auditor
Noble Medichem Private Limited is audited by B M Mehta & Co. for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B M Mehta & Co. | FY 2025 | 106188W |
Shareholding
The shareholding of Noble Medichem Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Noble Medichem Private Limited, buy the company report.
Charges & borrowings
Open charges
₹42.12 Cr
Satisfied charges
₹32.9 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Dec 2024 | 101029023 | Yes Bank Limited | ₹15 Cr | Open | |
| 18 Nov 2024 | 101028481 | Hdfc Bank Limited | ₹12.87 Lakh | Open | |
| 17 Aug 2024 | 100981949 | Hdfc Bank Limited | ₹80 Lakh | Open | |
| 26 Feb 2022 | 100552855 | Others | ₹26.2 Cr | Open | |
| 07 Oct 2023 | 100814742 | Others | ₹1.29 Cr | Satisfied |
To see the full charge records of Noble Medichem Private Limited, buy the company report.
Total charge records: 14 View all charges
Deals & funding
Noble Medichem Private Limited has 8 deals on record (6 secondary share transfers, 2 funding rounds), with disclosed funding of ₹34.99 Cr; the latest was in June 2024.
Total deals
8
Secondary share transfers
6
Funding rounds
2
Disclosed funding
₹34.99 Cr
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2024 | Funding round | ₹34 Cr | Investors: Tata Capital Healthcare Fund |
| Apr 2024 | Secondary share transfer | Undisclosed | Buyer: Tata Capital Healthcare Fund Seller: 3 individuals |
| Mar 2024 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Feb 2024 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Apr 2018 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 3 individuals |
To see the full deal history of Noble Medichem Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Noble Medichem Private Limited has 13 court cases on record: 6 filed by Noble Medichem, 7 filed against it. 5 cases are pending and 8 are disposed.
Total cases
13
Filed by the company
6
Filed against the company
7
Pending
5
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 13 | 7 | 5 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pune, Maharashtra | Civil suit | Filed against the company by an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed against the company by an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SS) | Filed against the company by an individual | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Civil suit | Filed by the company against individuals | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed by the company against an individual | Pending |
To see the full case history of Noble Medichem Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Noble Medichem Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Noble Medichem has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Noble Plus Online Private Limited | U74999MH2021PTC358544 |
To see the full group structure of Noble Medichem Private Limited, buy the company report.
Employees & EPFO
Noble Medichem Private Limited has a workforce of 226 employees on its EPFO records as of Jan 30, 2026, across 1 active EPFO establishment.
Employee count
226
Active EPFO establishments
1
Employee growth
5.61%
GST
Noble Medichem has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCM5010D1Z2 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Noble Medichem Private Limited, buy the company report.
Recent activity
Noble Medichem Private Limited has 8 board changes on record since 2007: 3 appointments and 5 cessations. The latest: Vamesh Bhupendra Chovatia ceased to be Additional Director on 18 Apr 2024.
Charges
A charge registered on 24 Sep 2021 via Charge ID 100490471 with Hdfc Bank Limited was fully satisfied on 06 May 2026.
Charges
A charge registered on 06 Sep 2021 via Charge ID 100477659 with Hdfc Bank Limited was fully satisfied on 06 Apr 2026.
Charges
A charge with Others of Rs. 26.20 Cr registered on 26 Feb 2022 with Charge ID 100552855 was modified on 31 Jan 2026.
AGM
Noble Medichem Private Limited last Annual general meeting of members was held on 19 Sep 2025 as per latest MCA records.
Charges
A charge registered on 07 Oct 2023 via Charge ID 100814742 with Others was fully satisfied on 15 Apr 2025.
Filing
Noble Medichem Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge registered on 22 Dec 2022 via Charge ID 100668979 with Others was fully satisfied on 03 Mar 2025.
Charges
A charge registered on 25 Jun 2019 via Charge ID 100285855 with Others was fully satisfied on 03 Mar 2025.
Charges
A charge registered on 28 Feb 2019 via Charge ID 100244757 with Standard Chartered Bank was fully satisfied on 28 Feb 2025.
Charges
A charge registered on 19 Feb 2019 via Charge ID 100244748 with Standard Chartered Bank was fully satisfied on 28 Feb 2025.
Charges
A charge with Yes Bank Limited amounted to Rs. 15.00 Cr with Charge ID 101029023 was registered on 14 Dec 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.13 Cr with Charge ID 101028481 was registered on 18 Nov 2024.
27 earlier events are in the company report.
Frequently asked questions
Noble Medichem is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 October 1992 (34+ years old) and is registered under CIN U24100MH1992PTC069250.
Noble Medichem has 2 current directors:
- Mihir Bakul Kapadia - Director
- Anuj Dharmanath Pandey - Director
The latest financial statements of Noble Medichem on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 19 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Noble Medichem is 27AACCM5010D1Z2, registered in Maharashtra.
The CIN (Corporate Identification Number) of Noble Medichem is U24100MH1992PTC069250. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Noble Medichem has 13 court cases on record: 6 filed by the company and 7 filed against it. 5 are pending.
Noble Medichem was incorporated on 28 October 1992, making it 34+ years old. It is registered with the Registrar of Companies, Mumbai.
Noble Medichem has 8 deals on record (6 secondary share transfers, 2 funding rounds), with disclosed funding of ₹34.99 Cr; the latest was in June 2024.
Vamesh Bhupendra Chovatia ceased to be Additional Director on 18 Apr 2024. Vamesh Bhupendra Chovatia was appointed as Nominee Director on 18 Apr 2024. Rima Mihir Kapadia ceased to be Director on 10 Dec 2018. Noble Medichem has 8 board changes on record in total.
Yes, Noble Medichem is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-18-0051088).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages